Carrie Mathew

机构：University of the Witwatersrand

发表论文 6 篇 · 总被引 596 次 · h-index 3

代表论文

• Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial (2022 · The Lancet · 被引 584)
• Cabotegravir for Prevention of HIV-1 in Women: Results From HPTN 084, a Phase III, Randomised Controlled Trial (2022 · SSRN Electronic Journal · 被引 7)
• Pharmacologic evaluation of delayed long-acting cabotegravir administration among cisgender women in HPTN 084 (2024 · Antimicrobial Agents and Chemotherapy · 被引 3)
• Combining HIV prevention Options with Mental health service delivery for Adolescent girls and young women (CHOMA): results of a pilot hybrid effectiveness‐implementation randomized trial in South Africa (2025 · Journal of the International AIDS Society · 被引 2)
• Evaluation of pharmacokinetic interactions between long‐acting cabotegravir or emtricitabine/tenofovir disoproxil fumarate and hormonal contraceptive agents: a tertiary analysis of South African participants in HPTN 084 (2025 · Journal of the International AIDS Society)
• Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084 (2023 · Carolina Digital Repository (University of North Carolina at Chapel Hill))